Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Non-Current Deferred Tax Liability came in at $366.0 million in Q1 2026, down 23.91% year-on-year from $481.0 million in Q1 2025, and down 4.19% quarter-over-quarter from $382.0 million in Q4 2025.
Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Non-Current Deferred Tax Liability across 10 years of filings, most recently posting $366.0 million for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $366.0 million, down 23.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $366.0 million (down 23.91% YoY), and the FY2025 annual result was $382.0 million, down 53.01% from the prior year.
- Non-Current Deferred Tax Liability came in at $366.0 million for Q1 2026 at Elanco Animal Health, down from $382.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 billion in Q4 2022 to a low of $366.0 million in Q1 2026.
- The 5-year median for Non-Current Deferred Tax Liability is $567.0 million (2023), against an average of $599.8 million.
- Across the five-year window, Non-Current Deferred Tax Liability jumped 43.39% in 2024 and tumbled 53.01% in 2025, its largest moves.
- Elanco Animal Health's Non-Current Deferred Tax Liability stood at $1.1 billion in 2022, then slumped by 47.11% to $567.0 million in 2023, then soared by 43.39% to $813.0 million in 2024, then tumbled by 53.01% to $382.0 million in 2025, then retreated by 4.19% to $366.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $366.0 million (Q1 2026), $382.0 million (Q4 2025), and $478.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 366.00 Mn |
| Mar 31, 2026 | 366.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Dec 31, 2025 | 382.00 Mn |
| Sep 30, 2025 | 478.00 Mn |
| Sep 30, 2025 | 478.00 Mn |
| Jun 30, 2025 | 496.00 Mn |
| Jun 30, 2025 | 496.00 Mn |
| Mar 31, 2025 | 481.00 Mn |
| Mar 31, 2025 | 481.00 Mn |
| Dec 31, 2024 | 813.00 Mn |
| Dec 31, 2024 | 813.00 Mn |
| Sep 30, 2024 | 539.00 Mn |
| Sep 30, 2024 | 539.00 Mn |
| Jun 30, 2024 | 524.00 Mn |
| Jun 30, 2024 | 524.00 Mn |
| Mar 31, 2024 | 530.00 Mn |
| Mar 31, 2024 | 530.00 Mn |
| Dec 31, 2023 | 567.00 Mn |
| Dec 31, 2023 | 567.00 Mn |